BlackRock »

Cullinan Oncology shares owned by BlackRock

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by BlackRock

Quarter filed Position value Share count Share price at filing
2024-12-31 $53M 4.4M 12.18
2024-09-30 $73M 4.3M 16.74

More positions owned by BlackRock

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Mastercard Incorporated Cl A (MA)

View all positions for BlackRock

Top funds holding Cullinan Oncology

MPM Oncology Impact Management
BVF
BlackRock
Deerfield Management Company
Vanguard Group
Citadel Advisors
Paradigm Biocapital Advisors
Franklin Resources
State Street Corporation
Alliancebernstein
Blue Owl Capital Holdings
OrbiMed Advisors
Rtw Investments
VR Adviser
Dimensional Fund Advisors

View all funds holding Cullinan Oncology